The protective effect of 2-chloroadenosine against the development of amygdala kindling and on amygdala-kindled seizures

European Journal of Pharmacology
A S Abdul-GhaniH F Bradford

Abstract

The influence of 2-chloroadenosine, a non-metabolizable adenosine A1 receptor agonist, was tested on the development of electrically kindled amygdala and on the seizure responses of fully kindled rats. Focal intra-amygdaloid injection of 2-chloroadenosine (1-10 nmol/0.5 microl) 20 min before applying the daily kindling stimulus prevented the development of the kindling process. The behavioural seizure score and the afterdischarge duration were reduced below their initial values. The antiepileptogenic effects of 1 and 10 nmol of 2-chloroadenosine were reversible 8-10 days after withdrawal of the drug. When 2-chloroadenosine was tested on fully developed stage 5 amygdala-kindled seizures, it increased the generalised seizure threshold in a dose-dependent manner. A maximum efficiency of 125% (P < 0.001) was achieved with 5 nmol and the median effective dose was 0.55 nmol. Higher doses resulted in the reduced anticonvulsant effect (P < 0.05). With the same daily stimulation, 2-chloroadenosine 5 nmol in 0.5 microl vehicle, significantly reduced the maximum seizure score by 90%, the afterdischarge duration by 88% and completely blocked the generalised seizure duration. The antiseizure activity of the drug lasted for 3 days. In conclu...Continue Reading

References

Nov 1, 1992·Annals of Neurology·M J During, D D Spencer
Jan 25, 1991·European Journal of Pharmacology·A Baskys, R C Malenka
May 1, 1991·Journal of Neurochemistry·A M Young, H F Bradford
Jan 8, 1990·Brain Research·M J Croucher, H F Bradford
Mar 13, 1990·European Journal of Pharmacology·A G ChapmanB S Meldrum
Apr 1, 1986·British Journal of Pharmacology·B Ault, C M Wang
Jan 1, 1987·Molecular Aspects of Medicine·H F Bradford, D W Peterson
Sep 1, 1985·Epilepsia·M DragunowR Laverty
Mar 1, 1972·Electroencephalography and Clinical Neurophysiology·R J Racine
Sep 3, 1984·European Journal of Pharmacology·R CorradettiG Pepeu
Jan 1, 1981·Progress in Neurobiology·J W Phillis, P H Wu
May 18, 1984·Neuroscience Letters·R A BarracoR F Berman
May 21, 1982·Science·M J CroucherB S Meldrum
Jun 1, 1981·Epilepsia·J Coutinho-NettoH F Bradford
Sep 1, 1995·Stroke; a Journal of Cerebral Circulation·A BhardwajR J Traystman
Aug 15, 1994·Neuroscience Letters·M C Bellingham, A J Berger
Dec 1, 1995·Progress in Neurobiology·H F Bradford

❮ Previous
Next ❯

Citations

Apr 27, 2001·Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine·P M KochanekE K Jackson
Mar 7, 2001·European Journal of Pharmacology·K J ElliottM A Rea
Oct 12, 2002·Pharmacology, Biochemistry, and Behavior·Eric SouthamPhilip F Morgan
Feb 11, 2003·Epilepsy Research·Sharon C StrattonRussell M Hagan
Mar 2, 2002·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Kinga K BorowiczStanisław J Czuczwar
Apr 3, 2010·Pharmacological Reports : PR·Marie PometlováPavel Mares
Sep 13, 2011·Progress in Neurobiology·Geoffrey BurnstockPeter Illes
Jun 3, 2005·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Patrick M KochanekChien Ho
Apr 26, 2011·Seizure : the Journal of the British Epilepsy Association·Annelies Van DyckePaul Boon
May 25, 2002·Medical Hypotheses·R Machado-VieiraF Kapczinski
Nov 18, 2006·Canadian Journal of Physiology and Pharmacology·Parviz ShahabiAli Eslami-far
Dec 2, 2020·Pharmaceutics·Manuela Gernert, Malte Feja
Jan 6, 2021·International Journal of Molecular Sciences·Jeroen SpanogheRobrecht Raedt

❮ Previous
Next ❯

Related Concepts

Related Feeds

Amygdala and Midbrain Dopamine

The midbrain dopamine system is widely studied for its involvement in emotional and motivational behavior. Some of these neurons receive information from the amygdala and project throughout the cortex. When the circuit and transmission of dopamine is disrupted symptoms may present. Here is the latest research on the amygdala and midbrain dopamine.

Amygdala: Sensory Processes

Amygdalae, nuclei clusters located in the temporal lobe of the brain, play a role in memory, emotional responses, and decision-making. Here is the latest research on sensory processes in the amygdala.